A mechanistic 3D AI-powered map of genetic chILD
- Institution
- CINCINNATI CHILDRENS HOSP MED CTR, OH
- Principal investigator
- Yan Xu
- Funding
- $803K
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
ABSTRACT/SUMMARY Leveraging the technologies and infrastructure in our previous LungMAP phases, we will construct a multi-scale map of developing acinar and alveolar structures during normal childhood and in the setting of childhood interstitial lung disease (chILD) characterized by aberrant lung morphogenesis. Linked to gene variants, chILD provides a unique opportunity to understand key genetic pathways and cellular interactions of human acinar and alveolar development, in turn informing injury-repair associated with lung diseases throughout the lifespan. Working in a collaborative LungMAP3 consortium, including other Research Centers, the Data Coordinating Center (DCC), the Human Tissue Core (HTC), our LungMAP3 project will use single-cell and spatial multiomics, high-resolution confocal and electron microscopy, patient-derived iPSCs, and bioinformatics including AI tools to define, model, and predict normal and diseased lung development. The resulting mechanistic insights and enabling technologies will be disseminated to the entire lung community via disease atlases and web portals, as we have done during LungMAP1 and 2, to accelerate lung biology discoveries and disease therapies.
Research team
- Jichao ChenPI
- Kathryn Ann Wikenheiser-BrokampPI
- Yan XuPI
LOADING MOONBASE SCORE
Questions for CINCINNATI CHILDRENS HOSP MED CTR
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Cincinnati Childrens Hosp Med CtrNot yet scored
Cellular determinants of responsiveness to mTOR inhibitors in LAM
Yan Xu · $739K · 2025–2028
- NIH · Cincinnati Childrens Hosp Med CtrNot yet scored
Cell-Cell Signaling Driving HPV-Induced Respiratory Disease and Vaccine Response
Susanne I Wells · $95K · 2025–2030
- NIH · University of Pittsburgh at PittsburghNot yet scored
Peripheral and Central Pathways of α3 Glycine Receptors as Non-Opioid Molecular Targets to Treat Pain
Yan Xu · $600K · 2022–2027